de Gans J - Search Results

1

Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study.

Heckenberg SGB, de Gans J, Brouwer MC, Weisfelt M, Piet JR, Spanjaard L, van der Ende A, van de Beek D. Heckenberg SGB, et al. Among authors: de gans j. Medicine (Baltimore). 2008 Jul;87(4):185-192. doi: 10.1097/MD.0b013e318180a6b4. Medicine (Baltimore). 2008. PMID: 18626301 Free article.

2

Cognitive impairment in adults with good recovery after bacterial meningitis.

van de Beek D, Schmand B, de Gans J, Weisfelt M, Vaessen H, Dankert J, Vermeulen M. van de Beek D, et al. Among authors: de gans j. J Infect Dis. 2002 Oct 1;186(7):1047-52. doi: 10.1086/344229. Epub 2002 Sep 13. J Infect Dis. 2002. PMID: 12232850

3

Dexamethasone in adults with bacterial meningitis.

de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. de Gans J, et al. N Engl J Med. 2002 Nov 14;347(20):1549-56. doi: 10.1056/NEJMoa021334. N Engl J Med. 2002. PMID: 12432041 Free article. Clinical Trial.

4

Clinical features and prognostic factors in adults with bacterial meningitis.

van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. van de Beek D, et al. Among authors: de gans j. N Engl J Med. 2004 Oct 28;351(18):1849-59. doi: 10.1056/NEJMoa040845. N Engl J Med. 2004. PMID: 15509818 Free article.

5

Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series.

Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Weisfelt M, et al. Among authors: de gans j. Lancet Neurol. 2006 Feb;5(2):123-9. doi: 10.1016/S1474-4422(05)70288-X. Lancet Neurol. 2006. PMID: 16426988

6

Pneumococcal meningitis in adults: new approaches to management and prevention.

Weisfelt M, de Gans J, van der Poll T, van de Beek D. Weisfelt M, et al. Among authors: de gans j. Lancet Neurol. 2006 Apr;5(4):332-42. doi: 10.1016/S1474-4422(06)70409-4. Lancet Neurol. 2006. PMID: 16545750 Review.

7

Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study.

Weisfelt M, van de Beek D, Spanjaard L, de Gans J. Weisfelt M, et al. Among authors: de gans j. BMC Infect Dis. 2006 Mar 29;6:64. doi: 10.1186/1471-2334-6-64. BMC Infect Dis. 2006. PMID: 16571115 Free PMC article.

8

Dexamethasone in adults with community-acquired bacterial meningitis.

van de Beek D, de Gans J. van de Beek D, et al. Among authors: de gans j. Drugs. 2006;66(4):415-27. doi: 10.2165/00003495-200666040-00002. Drugs. 2006. PMID: 16597160 Review.

9

Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis.

Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ, van de Beek D. Determann RM, et al. Among authors: de gans j. Intensive Care Med. 2006 Aug;32(8):1243-7. doi: 10.1007/s00134-006-0240-4. Epub 2006 Jun 20. Intensive Care Med. 2006. PMID: 16786330

10

Dexamethasone and long-term outcome in adults with bacterial meningitis.

Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA. Weisfelt M, et al. Among authors: de gans j. Ann Neurol. 2006 Oct;60(4):456-68. doi: 10.1002/ana.20944. Ann Neurol. 2006. PMID: 16958121 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters